✦ LIBER ✦

383 Plasminogen activator inhibitors type 1 and type 2 (PAI-1 and PAI-2) in normal pregnancy and in patients with severe preeclampsia

✍ Scribed by Estellés, A.; Gilabert, J.; Aznar, J.; Schleef, R.R.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Urokinase-type plasminogen activator and

✍ A Daneri-Navarro; G Macias-Lopez; A Oceguera-Villanueva; S Del Toro-Arreola; A B 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 62 KB

Plasminogen activator inhibitors (PAI-1

✍ A. Reith; N. A. Booth; N. R. Moore; D. J. Cruickshank; B. Bennett 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 529 KB

Plasminogen activator inhibitors (PAI-1

✍ A. Reith; N.A. Booth; N.R. Moore; D.J. Cruickshank; B. Bennett 📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 139 KB

44 Low expression of plasminogen activat

📂 Article 📅 1996 🏛 Elsevier Science 🌐 English ⚖ 135 KB

191 Urokinase type plasminogen activator

📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 94 KB

Plasminogen activator inhibitor-1 (PAI-1

✍ L. Brazionis; J. Yau; K. Rowley; C. Itsiopoulos; K. O’Dea; T.Y. Wong; A. Jenkins 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 226 KB